We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
UBALD2 is not prognostic in Pancreatic Adenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
104.3
Number of samples
176
Samples
Sample
Description
TPM
TCGA-2L-AAQJ-01A
0 years, female, white, stage:Stage III, dead, 394 days
332.8
TCGA-HZ-8005-01A
0 years, male, white, stage:Stage IIB, dead, 120 days
289.3
TCGA-FB-A5VM-01A
0 years, male, white, stage:Stage IB, dead, 498 days
265.6
TCGA-HV-A7OL-01A
0 years, male, asian, stage:Stage IIA, alive, 252 days
227.6
TCGA-IB-A7LX-01A
0 years, male, white, stage:Stage IIB, dead, 250 days
225.9
TCGA-FB-A545-01A
0 years, female, white, stage:Stage IIB, dead, 732 days
224.1
TCGA-IB-A5SS-01A
0 years, female, white, stage:Stage IIB, dead, 460 days
222.4
TCGA-FB-AAPU-01A
0 years, female, asian, stage:Stage IIA, dead, 381 days
212.8
TCGA-M8-A5N4-01A
0 years, female, stage:Stage IIA, alive, 584 days
208.7
TCGA-PZ-A5RE-01A
0 years, female, white, stage:Stage IIB, dead, 470 days
208.6
TCGA-US-A776-01A
0 years, male, white, stage:Stage IIA, alive, 1216 days
198.5
TCGA-3A-A9IU-01A
0 years, male, white, stage:Stage IIB, dead, 458 days
195.1
TCGA-HV-A7OP-01A
0 years, male, asian, stage:Stage IIB, alive, 978 days
193.2
TCGA-2J-AAB1-01A
0 years, male, white, stage:Stage IIB, dead, 66 days
192.3
TCGA-HZ-7926-01A
0 years, male, black or african american, stage:Stage IIB, dead, 518 days
188.1
TCGA-IB-AAUO-01A
0 years, female, white, stage:Stage IIB, dead, 239 days
187.5
TCGA-FB-A78T-01A
0 years, female, white, stage:Stage IIB, dead, 375 days
178.8
TCGA-IB-7646-01A
0 years, male, white, stage:Stage IIB, dead, 145 days
177.9
TCGA-OE-A75W-01A
0 years, male, white, stage:Stage IIA, dead, 267 days
175.1
TCGA-S4-A8RM-01A
0 years, male, white, stage:Stage IIB, alive, 737 days
174.2
TCGA-IB-A7M4-01A
0 years, male, white, stage:Stage IIB, alive, 483 days
173.0
TCGA-HZ-A4BK-01A
0 years, male, white, stage:Stage IIB, alive, 657 days
172.3
TCGA-HV-AA8X-01A
0 years, female, asian, stage:Stage IIB, dead, 532 days
168.1
TCGA-FB-AAPQ-01A
0 years, male, white, stage:Stage IIB, dead, 1130 days
166.7
TCGA-3A-A9I5-01A
0 years, male, white, stage:'--, alive, 1794 days
166.6
TCGA-2J-AABU-01A
0 years, male, white, stage:Stage IIB, dead, 277 days
163.3
TCGA-2J-AABI-01A
0 years, female, white, stage:Stage IIA, alive, 969 days
158.9
TCGA-S4-A8RO-01A
0 years, female, white, stage:Stage IIB, alive, 525 days
157.6
TCGA-FB-A7DR-01A
0 years, male, asian, stage:Stage IIA, dead, 353 days
156.1
TCGA-IB-7890-01A
0 years, male, stage:Stage IB, dead, 598 days
150.3
TCGA-F2-6879-01A
0 years, male, white, stage:Stage IIB, dead, 334 days
150.1
TCGA-IB-A6UF-01A
0 years, male, white, stage:Stage IIB, alive, 666 days
147.9
TCGA-HZ-7924-01A
0 years, female, white, stage:Stage IIA, alive, 840 days
147.3
TCGA-US-A77E-01A
0 years, male, white, stage:Stage IIB, dead, 430 days
146.2
TCGA-L1-A7W4-01A
0 years, female, white, stage:Stage IIB, dead, 278 days
145.0
TCGA-HV-A5A6-01A
0 years, female, asian, stage:Stage IIB, dead, 2036 days
144.5
TCGA-3E-AAAZ-01A
0 years, male, white, stage:Stage IIA, dead, 2182 days
144.2
TCGA-3A-A9IH-01A
0 years, female, white, stage:Stage IA, alive, 1021 days
143.0
TCGA-IB-A5SQ-01A
0 years, female, white, stage:Stage IB, dead, 219 days
138.2
TCGA-HZ-A9TJ-01A
0 years, male, white, stage:Stage IV, alive, 603 days
137.4
TCGA-YY-A8LH-01A
0 years, female, white, stage:Stage IIB, alive, 2016 days
136.4
TCGA-YH-A8SY-01A
0 years, female, white, stage:'--, alive, 388 days
136.2
TCGA-HV-A5A3-01A
0 years, male, asian, stage:Stage IIA, dead, 128 days
134.5
TCGA-IB-AAUU-01A
0 years, male, white, stage:Stage IIB, alive, 245 days
133.8
TCGA-US-A77G-01A
0 years, male, white, stage:Stage IIB, dead, 12 days
131.9
TCGA-IB-7651-01A
0 years, female, white, stage:Stage IIB, dead, 603 days
128.9
TCGA-IB-A5SO-01A
0 years, male, white, stage:Stage IIB, dead, 365 days
128.2
TCGA-3A-A9IB-01A
0 years, female, white, stage:Stage IIB, dead, 224 days
126.9
TCGA-IB-AAUS-01A
0 years, female, white, stage:Stage IIB, alive, 225 days
125.5
TCGA-HZ-A77Q-01A
0 years, female, white, stage:Stage IIB, alive, 33 days
125.2
TCGA-US-A779-01A
0 years, female, white, stage:Stage IIB, dead, 511 days
123.6
TCGA-F2-A44G-01A
0 years, female, white, stage:Stage IIB, dead, 233 days
123.3
TCGA-RB-A7B8-01A
0 years, female, white, stage:Stage IIB, dead, 466 days
122.8
TCGA-HZ-A8P1-01A
0 years, male, white, stage:Stage IB, alive, 7 days
122.8
TCGA-F2-A7TX-01A
0 years, male, white, stage:Stage IIB, dead, 95 days
122.3
TCGA-FB-AAPZ-01A
0 years, male, white, stage:Stage IIB, alive, 716 days
122.2
TCGA-2J-AABH-01A
0 years, male, white, stage:Stage IIA, alive, 1287 days
118.4
TCGA-F2-A8YN-01A
0 years, male, white, stage:Stage IIA, alive, 517 days
116.5
TCGA-HZ-7925-01A
0 years, male, white, stage:Stage IIB, dead, 614 days
116.2
TCGA-H6-8124-01A
0 years, female, white, stage:Stage IIB, alive, 392 days
115.8
TCGA-FB-AAQ1-01A
0 years, male, white, stage:Stage IIB, dead, 123 days
115.8
TCGA-IB-8127-01A
0 years, male, white, stage:Stage IIB, alive, 522 days
115.3
TCGA-3A-A9J0-01A
0 years, male, white, stage:Stage IIB, alive, 743 days
114.1
TCGA-XD-AAUL-01A
0 years, male, white, stage:Stage IIA, alive, 498 days
113.0
TCGA-IB-AAUQ-01A
0 years, male, white, stage:Stage IIB, dead, 183 days
110.4
TCGA-IB-7885-01A
0 years, female, white, stage:Stage IIB, alive, 1257 days
107.8
TCGA-3A-A9IZ-01A
0 years, male, white, stage:Stage IIB, dead, 308 days
105.8
TCGA-HV-A5A4-01A
0 years, female, asian, stage:Stage IIA, alive, 232 days
105.3
TCGA-IB-7654-01A
0 years, male, white, stage:Stage IIB, dead, 476 days
104.3
TCGA-IB-7644-01A
0 years, female, white, stage:Stage IV, dead, 394 days
104.2
TCGA-2L-AAQA-01A
0 years, male, white, stage:Stage IIB, dead, 143 days
103.6
TCGA-IB-A5ST-01A
0 years, female, white, stage:Stage IIB, alive, 635 days
103.1
TCGA-FB-AAQ2-01A
0 years, female, white, stage:Stage IIB, dead, 153 days
103.0
TCGA-Q3-AA2A-01A
0 years, female, white, stage:Stage IB, alive, 95 days
102.1
TCGA-LB-A7SX-01A
0 years, female, black or african american, stage:Stage IIB, dead, 393 days
101.7
TCGA-2J-AAB4-01A
0 years, male, white, stage:Stage IIB, alive, 729 days
101.0
TCGA-US-A77J-01A
0 years, female, white, stage:Stage IIB, dead, 568 days
100.6
TCGA-FB-AAPY-01A
0 years, male, white, stage:Stage IIB, dead, 1059 days
100.5
TCGA-HZ-A77O-01A
0 years, female, white, stage:Stage IIB, dead, 160 days
100.2
TCGA-HZ-A49I-01A
0 years, male, white, stage:Stage IIB, dead, 308 days
98.0
TCGA-IB-AAUN-01A
0 years, female, white, stage:Stage IB, dead, 144 days
97.6
TCGA-HZ-8315-01A
0 years, female, white, stage:Stage IIA, dead, 299 days
97.4
TCGA-IB-AAUP-01A
0 years, male, white, stage:Stage IIB, alive, 431 days
97.0
TCGA-2L-AAQI-01A
0 years, male, white, stage:Stage IIB, dead, 103 days
96.7
TCGA-F2-7273-01A
0 years, male, black or african american, stage:Stage IIB, dead, 592 days
96.5
TCGA-FB-AAQ6-01A
0 years, male, white, stage:Stage IA, dead, 244 days
96.5
TCGA-XN-A8T3-01A
0 years, male, white, stage:Stage IB, alive, 951 days
95.9
TCGA-S4-A8RP-01A
0 years, female, white, stage:Stage IIB, dead, 702 days
95.5
TCGA-2J-AABR-01A
0 years, female, white, stage:Stage IIA, alive, 438 days
94.9
TCGA-LB-A8F3-01A
0 years, female, black or african american, stage:Stage IIA, alive, 379 days
94.3
TCGA-FB-A4P6-01A
0 years, male, white, stage:Stage IIB, alive, 767 days
93.4
TCGA-H8-A6C1-01A
0 years, male, white, stage:Stage IIA, alive, 671 days
91.8
TCGA-Q3-A5QY-01A
0 years, male, white, stage:Stage IIB, alive, 416 days
90.9
TCGA-2L-AAQL-01A
0 years, male, white, stage:Stage IIB, dead, 292 days
89.7
TCGA-3A-A9I7-01A
0 years, male, black or african american, stage:Stage IIB, alive, 1323 days
89.5
TCGA-FB-AAPS-01A
0 years, female, white, stage:Stage IIB, alive, 228 days
89.4
TCGA-2J-AABF-01A
0 years, male, white, stage:Stage IIB, dead, 691 days
88.9
TCGA-US-A774-01A
0 years, female, white, stage:Stage IIB, dead, 695 days
88.9
TCGA-HV-AA8V-01A
0 years, male, asian, stage:Stage IIB, alive, 920 days
86.7
TCGA-HZ-7289-01A
0 years, male, white, stage:Stage IIB, dead, 661 days
85.6
TCGA-2J-AAB6-01A
0 years, male, white, stage:Stage IIA, dead, 293 days
85.5
TCGA-IB-AAUT-01A
0 years, male, white, stage:Stage IIB, alive, 287 days
85.0
TCGA-IB-A6UG-01A
0 years, male, white, stage:Stage IIB, dead, 41 days
83.5
TCGA-IB-7652-01A
0 years, female, asian, stage:Stage IIB, alive, 1116 days
83.1
TCGA-F2-7276-01A
0 years, male, white, stage:Stage IIB, dead, 216 days
82.6
TCGA-HZ-8519-01A
0 years, male, white, stage:Stage IA, alive, 454 days
81.6
TCGA-IB-AAUR-01A
0 years, male, white, stage:Stage IIB, alive, 338 days
81.3
TCGA-HZ-A77P-01A
0 years, male, white, stage:Stage IIB, alive, 330 days
80.6
TCGA-HZ-8636-01A
0 years, female, white, stage:Stage IV, dead, 545 days
80.5
TCGA-2J-AABT-01A
0 years, female, white, stage:Stage IIB, alive, 319 days
80.2
TCGA-3E-AAAY-01A
0 years, male, white, stage:Stage IIB, alive, 2285 days
78.8
TCGA-RL-AAAS-01A
0 years, female, white, stage:Stage IB, alive, 9 days
78.7
TCGA-XD-AAUI-01A
0 years, female, white, stage:Stage IIB, dead, 366 days
78.4
TCGA-2J-AABE-01A
0 years, male, white, stage:Stage IIA, alive, 676 days
78.3
TCGA-Z5-AAPL-01A
0 years, female, white, stage:Stage IIA, alive, 467 days
77.7
TCGA-FB-A4P5-01A
0 years, female, white, stage:Stage IIB, dead, 179 days
76.4
TCGA-3A-A9IC-01A
0 years, female, white, stage:Stage IIB, dead, 738 days
76.0
TCGA-2J-AABO-01A
0 years, male, white, stage:Stage IIB, alive, 440 days
75.9
TCGA-YB-A89D-01A
0 years, male, white, stage:Stage IIB, alive, 350 days
75.3
TCGA-HZ-8638-01A
0 years, female, white, stage:Stage IA, dead, 151 days
75.3
TCGA-HZ-7923-01A
0 years, male, white, stage:Stage IIA, alive, 314 days
74.4
TCGA-XN-A8T5-01A
0 years, female, white, stage:Stage IB, alive, 720 days
73.8
TCGA-2J-AABP-01A
0 years, female, white, stage:Stage IIB, alive, 463 days
73.5
TCGA-IB-A5SP-01A
0 years, male, white, stage:Stage IIA, alive, 482 days
73.1
TCGA-2J-AAB9-01A
0 years, female, white, stage:Stage IIB, dead, 627 days
73.0
TCGA-2J-AABA-01A
0 years, male, white, stage:Stage IIB, dead, 607 days
72.3
TCGA-H6-A45N-01A
0 years, female, white, stage:Stage IIB, dead, 397 days
72.2
TCGA-3A-A9IR-01A
0 years, female, white, stage:Stage IB, alive, 1542 days
71.0
TCGA-FB-AAQ3-01A
0 years, female, white, stage:Stage IIB, dead, 31 days
69.4
TCGA-IB-AAUW-01A
0 years, female, white, stage:Stage IIB, dead, 230 days
69.3
TCGA-HZ-A4BH-01A
0 years, male, white, stage:Stage IIB, alive, 194 days
68.9
TCGA-2L-AAQE-01A
0 years, male, white, stage:Stage IIB, dead, 684 days
68.4
TCGA-3A-A9IL-01A
0 years, female, white, stage:Stage I, alive, 2741 days
67.7
TCGA-HZ-A49G-01A
0 years, female, white, stage:Stage IIB, alive, 660 days
65.8
TCGA-HZ-7922-01A
0 years, female, white, stage:Stage IIB, alive, 4 days
65.1
TCGA-RB-AA9M-01A
0 years, male, white, stage:Stage IIB, alive, 286 days
64.4
TCGA-FB-AAPP-01A
0 years, male, white, stage:Stage IIB, dead, 485 days
64.1
TCGA-2L-AAQM-01A
0 years, male, white, stage:Stage IIB, alive, 1383 days
63.0
TCGA-HV-A5A5-01A
0 years, female, asian, stage:Stage IIB, alive, 289 days
62.6
TCGA-IB-7887-01A
0 years, female, white, stage:Stage IIB, dead, 110 days
62.5
TCGA-HZ-8317-01A
0 years, female, white, stage:Stage IIB, dead, 378 days
62.4
TCGA-HZ-8637-01A
0 years, female, white, stage:Stage IIB, dead, 517 days
60.2
TCGA-HZ-7919-01A
0 years, female, white, stage:Stage IIB, dead, 593 days
57.9
TCGA-2J-AABK-01A
0 years, male, white, stage:Stage IIB, alive, 484 days
57.5
TCGA-IB-7889-01A
0 years, female, white, stage:Stage IIB, dead, 481 days
55.7
TCGA-3A-A9IJ-01A
0 years, male, white, stage:Stage IB, alive, 1854 days
55.6
TCGA-3A-A9IN-01A
0 years, female, white, stage:Stage IB, alive, 2084 days
55.4
TCGA-FB-AAQ0-01A
0 years, male, white, stage:Stage IIA, dead, 473 days
55.2
TCGA-IB-7891-01A
0 years, female, white, stage:Stage IIB, dead, 913 days
54.9
TCGA-IB-7645-01A
0 years, female, stage:Stage IIB, dead, 1502 days
53.7
TCGA-XD-AAUH-01A
0 years, female, white, stage:Stage IIB, alive, 395 days
53.1
TCGA-3A-A9IS-01A
0 years, male, white, stage:Stage IB, alive, 998 days
52.9
TCGA-IB-AAUV-01A
0 years, male, white, stage:Stage IIB, alive, 404 days
52.8
TCGA-3A-A9IX-01A
0 years, male, white, stage:Stage IA, alive, 1037 days
52.6
TCGA-2J-AAB8-01A
0 years, male, white, stage:Stage IIB, alive, 80 days
51.8
TCGA-3A-A9I9-01A
0 years, male, white, stage:Stage IIA, dead, 634 days
50.5
TCGA-HZ-8001-01A
0 years, male, white, stage:Stage III, alive, 706 days
49.6
TCGA-F2-A44H-01A
0 years, male, white, stage:Stage IIA, alive, 586 days
47.1
TCGA-IB-7649-01A
0 years, female, stage:Stage IIB, dead, 467 days
45.9
TCGA-IB-AAUM-01A
0 years, male, white, stage:Stage IIB, alive, 8 days
45.1
TCGA-IB-7886-01A
0 years, male, white, stage:Stage IIB, dead, 123 days
42.9
TCGA-HZ-A49H-01A
0 years, female, white, stage:Stage IIB, alive, 491 days
42.3
TCGA-XD-AAUG-01A
0 years, female, white, stage:Stage IV, alive, 420 days
37.8
TCGA-HZ-8002-01A
0 years, male, white, stage:Stage IIB, dead, 366 days
36.3
TCGA-3A-A9IV-01A
0 years, female, white, stage:Stage IB, alive, 1103 days
34.7
TCGA-LB-A9Q5-01A
0 years, female, white, stage:Stage IIB, dead, 313 days
34.2
TCGA-IB-7893-01A
0 years, male, white, stage:Stage IIA, dead, 117 days
33.8
TCGA-IB-7897-01A
0 years, female, white, stage:Stage IIB, dead, 486 days
31.6
TCGA-IB-7888-01A
0 years, female, black or african american, stage:Stage IIA, dead, 1332 days
31.5
TCGA-HZ-7918-01A
0 years, male, white, stage:Stage IIB, alive, 969 days
31.0
TCGA-2J-AABV-01A
0 years, male, white, stage:Stage IIB, dead, 652 days
28.3
TCGA-HZ-7920-01A
0 years, male, white, stage:Stage IB, dead, 236 days
25.9
TCGA-HZ-8003-01A
0 years, female, white, stage:Stage IIB, dead, 596 days
24.6
TCGA-IB-8126-01A
0 years, female, white, stage:Stage III, alive, 462 days
23.6
TCGA-3A-A9IO-01A
0 years, male, white, stage:'--, alive, 1942 days
22.7
TCGA-F2-6880-01A
0 years, male, white, stage:Stage IIB, alive, 295 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
UBALD2 is not prognostic in Pancreatic Adenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
15.7
Number of samples
80
Samples
Sample
Description
TPM
DO49079
0 years, male, NA, stage:, dead, 332 days
43.4
DO34504
0 years, male, NA, stage:, dead, 257 days
31.4
DO32875
0 years, male, NA, stage:, dead, 348 days
30.3
DO34616
0 years, female, NA, stage:, alive, 666 days
28.5
DO34905
0 years, male, NA, stage:, alive, 1142 days
27.6
DO34600
0 years, male, NA, stage:, dead, 537 days
25.8
DO34640
0 years, female, NA, stage:, dead, 287 days
25.0
DO32878
0 years, female, NA, stage:, dead, 260 days
24.8
DO49198
0 years, female, NA, stage:, dead, 251 days
24.1
DO49135
0 years, male, NA, stage:, alive, 270 days
24.0
DO34240
0 years, male, NA, stage:, dead, 236 days
22.7
DO49168
0 years, male, NA, stage:, alive, 149 days
22.5
DO34785
0 years, female, NA, stage:, alive, 721 days
22.3
DO34656
0 years, female, NA, stage:, alive, 834 days
21.5
DO49166
0 years, female, NA, stage:, alive, 222 days
21.4
DO49193
0 years, male, NA, stage:, dead, 1 days
20.3
DO34608
0 years, female, NA, stage:, dead, 709 days
20.1
DO49074
0 years, male, NA, stage:, dead, 168 days
19.8
DO34696
0 years, male, NA, stage:, alive, 689 days
19.7
DO49183
0 years, female, NA, stage:, dead, 429 days
19.5
DO33512
female, NA, stage:, dead, 499 days
19.5
DO34720
0 years, male, NA, stage:, alive, 555 days
19.4
DO49080
0 years, male, NA, stage:, alive, 83 days
19.4
DO34680
0 years, male, NA, stage:, dead, 99 days
18.9
DO33336
0 years, female, NA, stage:, dead, 451 days
18.5
DO49164
0 years, male, NA, stage:, alive, 272 days
18.1
DO34793
0 years, male, NA, stage:, dead, 427 days
17.3
DO49137
0 years, female, NA, stage:, alive, 232 days
17.2
DO34728
0 years, female, NA, stage:, alive, 508 days
16.6
DO34961
0 years, male, NA, stage:, dead, 632 days
16.4
DO33408
0 years, female, NA, stage:, alive, 909 days
16.2
DO33392
0 years, male, NA, stage:, alive, 1014 days
16.2
DO33400
0 years, female, NA, stage:, alive, 1043 days
16.2
DO49090
0 years, female, NA, stage:, dead, 152 days
15.9
DO49204
0 years, male, NA, stage:, dead, 156 days
15.9
DO34817
0 years, female, NA, stage:, alive, 540 days
15.7
DO33488
0 years, male, NA, stage:, alive, 844 days
15.4
DO33544
0 years, female, NA, stage:, dead, 412 days
15.4
DO49185
0 years, male, NA, stage:, alive, 179 days
15.1
DO49113
0 years, female, NA, stage:, alive, 413 days
14.9
DO49129
0 years, male, NA, stage:, alive, 337 days
14.9
DO34801
0 years, male, NA, stage:, alive, 626 days
14.7
DO32829
0 years, female, NA, stage:T2N0MX, dead, 1874 days
14.1
DO33128
0 years, male, NA, stage:, dead, 423 days
14.0
DO49133
0 years, female, NA, stage:, alive, 188 days
13.6
DO33552
0 years, female, NA, stage:, alive, 873 days
13.4
DO49178
0 years, male, NA, stage:, dead, 27 days
13.3
DO49087
0 years, female, NA, stage:, dead, 260 days
13.0
DO32863
0 years, male, NA, stage:, dead, 715 days
13.0
DO33480
0 years, male, NA, stage:, alive, 1054 days
13.0
DO33344
0 years, male, NA, stage:, dead, 361 days
12.8
DO34368
0 years, female, NA, stage:, dead, 537 days
12.5
DO34736
0 years, female, NA, stage:, dead, 203 days
12.2
DO33376
0 years, female, NA, stage:, alive, 909 days
12.2
DO34288
0 years, female, NA, stage:, dead, 220 days
12.0
DO49078
0 years, male, NA, stage:, dead, 465 days
11.8
DO49170
0 years, male, NA, stage:, alive, 197 days
11.6
DO49127
0 years, female, NA, stage:, alive, 392 days
11.4
DO34432
0 years, female, NA, stage:, dead, 400 days
11.0
DO33472
0 years, female, NA, stage:, dead, 388 days
10.7
DO34849
0 years, female, NA, stage:, dead, 272 days
10.7
DO33600
0 years, female, NA, stage:, alive, 854 days
10.4
DO32900
0 years, male, NA, stage:, dead, 768 days
10.4
DO32860
0 years, male, NA, stage:, dead, 1259 days
10.3
DO49199
0 years, male, NA, stage:, dead, 1095 days
9.9
DO34264
0 years, female, NA, stage:, dead, 1144 days
9.9
DO34448
0 years, female, NA, stage:, dead, 719 days
9.9
DO49138
0 years, male, NA, stage:, dead, 230 days
9.7
DO49172
0 years, female, NA, stage:, dead, 1021 days
9.7
DO49130
0 years, female, NA, stage:, alive, 351 days
9.6
DO34312
0 years, female, NA, stage:, dead, 226 days
9.5
DO49181
0 years, male, NA, stage:, dead, 1534 days
9.0
DO49076
0 years, male, NA, stage:, dead, 480 days
8.6
DO34809
0 years, female, NA, stage:, dead, 297 days
8.4
DO49175
0 years, male, NA, stage:, dead, 414 days
8.4
DO49184
0 years, male, NA, stage:, dead, 455 days
8.3
DO33984
0 years, male, NA, stage:, alive, 847 days
7.5
DO33168
0 years, female, NA, stage:, dead, 8 days
6.9
DO33368
0 years, male, NA, stage:, dead, 98 days
6.1
DO34336
0 years, female, NA, stage:, alive, 743 days
1.4
Show allShow less
PANCREATIC DUCTAL ADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
235
Samples
Sample ID
Sample type
nRPX
CPT0183770004
Normal
1.6
CPT0246950003
Normal
0.7
CPT0276030003
Normal
0.5
CPT0088260004
Tumor
0.5
CPT0246260004
Tumor
0.4
CPT0093930004
Tumor
0.4
CPT0246940003
Tumor
0.2
CPT0276010003
Tumor
0.1
CPT0183750005
Tumor
0.1
CPT0217700004
Tumor
0.0
CPT0235230004
Tumor
0.0
CPT0108400003
Tumor
-0.1
CPT0174700004
Tumor
-0.1
CPT0170260004
Normal
-0.1
CPT0226610004
Normal
-0.2
CPT0226600004
Tumor
-0.2
CPT0186040004
Tumor
-0.2
CPT0170240004
Tumor
-0.2
CPT0109010004
Tumor
-0.3
CPT0124360003
Tumor
-0.3
CPT0091660003
Tumor
-0.3
CPT0174800003
Normal
-0.3
CPT0123440003
Tumor
-0.4
CPT0161770004
Tumor
-0.4
CPT0246810003
Tumor
-0.4
CPT0123460003
Normal
-0.4
CPT0065570003
Tumor
-0.6
CPT0091680003
Normal
-0.7
CPT0208710004
Normal
N/A
CPT0065640003
Tumor
N/A
CPT0226570004
Tumor
N/A
CPT0093980004
Tumor
N/A
CPT0086210003
Normal
N/A
CPT0123770003
Normal
N/A
CPT0247050003
Normal
N/A
CPT0063580003
Normal
N/A
CPT0236340004
Tumor
N/A
CPT0236710004
Normal
N/A
C3N-02573-03
Normal
N/A
CPT0238530005
Tumor
N/A
CPT0347880002
Normal
N/A
CPT0161990005
Tumor
N/A
CPT0081060004
Tumor
N/A
CPT0124410004
Tumor
N/A
CPT0207990004
Normal
N/A
CPT0198910005
Tumor
N/A
CPT0019300004
Tumor
N/A
CPT0125130003
Tumor
N/A
CPT0198700005
Tumor
N/A
CPT0226650004
Tumor
N/A
CPT0239140004
Normal
N/A
CPT0187930005
Tumor
N/A
CPT0000250017
Tumor
N/A
CPT0081360004
Tumor
N/A
CPT0208690004
Tumor
N/A
CPT0166780004
Normal
N/A
CPT0241510004
Normal
N/A
CPT0125090003
Tumor
N/A
CPT0063570003
Tumor
N/A
CPT0108410003
Normal
N/A
CPT0123990003
Tumor
N/A
CPT0236780005
Tumor
N/A
CPT0078160004
Tumor
N/A
CPT0248320003
Normal
N/A
CPT0014040003
Tumor
N/A
CPT0248410004
Tumor
N/A
CPT0241500004
Tumor
N/A
CPT0208850004
Normal
N/A
CPT0247040003
Tumor
N/A
CPT0183450005
Tumor
N/A
CPT0125010003
Normal
N/A
CPT0094740004
Tumor
N/A
CPT0185920004
Tumor
N/A
CPT0226680005
Tumor
N/A
CPT0011540003
Normal
N/A
CPT0094030003
Tumor
N/A
CPT0166650006
Tumor
N/A
CPT0203850004
Tumor
N/A
CPT0094230004
Tumor
N/A
CPT0209650004
Normal
N/A
CPT0224470004
Normal
N/A
CPT0238940004
Normal
N/A
CPT0123650003
Tumor
N/A
C3L-01687-04
Normal
N/A
CPT0198930003
Normal
N/A
CPT0239920004
Normal
N/A
CPT0162670004
Normal
N/A
CPT0218200004
Tumor
N/A
CPT0226760004
Tumor
N/A
CPT0138890003
Normal
N/A
CPT0237850004
Normal
N/A
CPT0208840004
Tumor
N/A
CPT0123860003
Tumor
N/A
CPT0088320003
Tumor
N/A
CPT0064110003
Normal
N/A
CPT0109110004
Tumor
N/A
CPT0227930004
Tumor
N/A
CPT0066020003
Normal
N/A
CPT0247000003
Normal
N/A
CPT0025750003
Tumor
N/A
CPT0094630004
Tumor
N/A
CPT0239100009
Tumor
N/A
CPT0248620003
Normal
N/A
CPT0077930004
Tumor
N/A
CPT0078250003
Tumor
N/A
CPT0355190003
Normal
N/A
CPT0078030003
Normal
N/A
CPT0347760002
Normal
N/A
C3L-00401-04
Normal
N/A
CPT0197440004
Normal
N/A
CPT0081260004
Tumor
N/A
CPT0086190004
Tumor
N/A
CPT0087890004
Tumor
N/A
CPT0077810003
Normal
N/A
CPT0109300004
Tumor
N/A
CPT0019410004
Tumor
N/A
CPT0246840003
Tumor
N/A
CPT0236800004
Normal
N/A
CPT0238820005
Tumor
N/A
CPT0017130003
Normal
N/A
CPT0008800003
Tumor
N/A
CPT0077790004
Tumor
N/A
CPT0001750003
Normal
N/A
CPT0237270005
Tumor
N/A
CPT0187550004
Tumor
N/A
KoreanReference3
Tumor
N/A
CPT0077860003
Tumor
N/A
WU-pooled sample
Tumor
N/A
KoreanReference2
Tumor
N/A
CPT0089750004
Normal
N/A
CPT0238740004
Normal
N/A
CPT0014060003
Normal
N/A
CPT0239910004
Tumor
N/A
CPT0238610009
Tumor
N/A
CPT0109130003
Normal
N/A
CPT0347850002
Normal
N/A
CPT0238040005
Tumor
N/A
CPT0089720003
Tumor
N/A
CPT0236700005
Tumor
N/A
CPT0138900004
Tumor
N/A
CPT0254680003
Tumor
N/A
CPT0064520004
Tumor
N/A
CPT0123890003
Normal
N/A
CPT0241320005
Tumor
N/A
CPT0246720003
Tumor
N/A
CPT0064570003
Normal
N/A
CPT0221250004
Normal
N/A
CPT0166680004
Normal
N/A
CPT0226530004
Tumor
N/A
CPT0064090003
Tumor
N/A
CPT0355200003
Normal
N/A
CPT0094760003
Normal
N/A
CPT0247090003
Tumor
N/A
CPT0198420004
Tumor
N/A
CPT0209310004
Tumor
N/A
CPT0093860003
Tumor
N/A
CPT0083270003
Tumor
N/A
CPT0237920004
Normal
N/A
CPT0093880003
Normal
N/A
CPT0246990003
Tumor
N/A
CPT0124530003
Normal
N/A
CPT0238710004
Tumor
N/A
CPT0063970004
Tumor
N/A
CPT0186050004
Normal
N/A
CPT0124610004
Tumor
N/A
CPT0237290004
Normal
N/A
KoreanReference1
Tumor
N/A
CPT0017040004
Tumor
N/A
CPT0248440003
Normal
N/A
CPT0198440004
Normal
N/A
CPT0123670003
Normal
N/A
CPT0077950003
Normal
N/A
CPT0248590004
Tumor
N/A
CPT0011520003
Tumor
N/A
CPT0264180003
Normal
N/A
CPT0124980004
Tumor
N/A
CPT0238440005
Tumor
N/A
CPT0207780004
Tumor
N/A
CPT0246210004
Tumor
N/A
CPT0094180003
Tumor
N/A
CPT0221470005
Tumor
N/A
CPT0108930003
Tumor
N/A
CPT0207980005
Tumor
N/A
CPT0109200004
Tumor
N/A
C3L-00189-04
Normal
N/A
CPT0008750003
Tumor
N/A
CPT0078090004
Tumor
N/A
CPT0238640004
Normal
N/A
CPT0237840004
Tumor
N/A
CPT0081470004
Tumor
N/A
CPT0127290003
Normal
N/A
CPT0264150003
Tumor
N/A
CPT0124500004
Tumor
N/A
CPT0187540004
Normal
N/A
CPT0209640005
Tumor
N/A
CPT0092630003
Tumor
N/A
CPT0063990003
Normal
N/A
CPT0124000003
Normal
N/A
CPT0208550005
Tumor
N/A
WU-PDA1
Tumor
N/A
CPT0138990003
Normal
N/A
CPT0127270003
Tumor
N/A
CPT0162660004
Tumor
N/A
CPT0094130004
Tumor
N/A
CPT0126200003
Normal
N/A
CPT0162760003
Tumor
N/A
CPT0246220004
Normal
N/A
CPT0001730017
Tumor
N/A
CPT0197420004
Tumor
N/A
C3L-03632-04
Normal
N/A
CPT0221240004
Tumor
N/A
CPT0347820002
Normal
N/A
CPT0226490004
Tumor
N/A
CPT0139000004
Tumor
N/A
CPT0126160004
Tumor
N/A
CPT0237910004
Tumor
N/A
CPT0025760003
Normal
N/A
CPT0198730004
Normal
N/A
CPT0355180003
Normal
N/A
CPT0224460004
Tumor
N/A
CPT0108960003
Normal
N/A
CPT0347790002
Normal
N/A
CPT0123750003
Tumor
N/A
CPT0236560004
Tumor
N/A
CPT0166760004
Tumor
N/A
CPT0238920004
Tumor
N/A
C3N-00709-06
Normal
N/A
CPT0077880003
Normal
N/A
CPT0078180003
Normal
N/A
CPT0088180004
Tumor
N/A
CPT0236360004
Normal
N/A
CPT0218220004
Normal
N/A
CPT0094940004
Tumor
N/A
CPT0078000003
Tumor
N/A
CPT0162780004
Normal
N/A
Show allShow less
PANCREATIC CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
